iSpecimen Statistics

Total Valuation

iSpecimen has a market cap or net worth of $2.55 million. The enterprise value is -$2.26 million.

Market Cap	2.55M
Enterprise Value	-2.26M

Important Dates

The next confirmed earnings date is Tuesday, May 7, 2024, before market open.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

iSpecimen has 9.09 million shares outstanding. The number of shares has increased by 2.23% in one year.

Shares Outstanding	9.09M
Shares Change (YoY)	+2.23%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	33.77%
Owned by Institutions (%)	4.31%
Float	6.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.26
Forward PS	0.22
PB Ratio	0.26
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.02.

Current Ratio	1.36
Quick Ratio	1.31
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-692.67

Financial Efficiency

Return on equity (ROE) is -80.40% and return on invested capital (ROIC) is -112.40%.

Return on Equity (ROE)	-80.40%
Return on Assets (ROA)	-62.00%
Return on Capital (ROIC)	-112.40%
Revenue Per Employee	$187,324
Profits Per Employee	-$209,424
Employee Count	53
Asset Turnover	0.55
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.02% in the last 52 weeks. The beta is 1.69, so iSpecimen's price volatility has been higher than the market average.

Beta (1Y)	1.69
52-Week Price Change	-83.02%
50-Day Moving Average	0.34
200-Day Moving Average	0.64
Relative Strength Index (RSI)	49.35
Average Volume (30 Days)	852,606

Short Selling Information

The latest short interest is 70,870, so 0.78% of the outstanding shares have been sold short.

Short Interest	70,870
Short Previous Month	459,449
Short % of Shares Out	0.78%
Short % of Float	1.03%
Short Ratio (days to cover)	0.18

Income Statement

In the last 12 months, iSpecimen had revenue of $9.93 million and -$11.10 million in losses. Loss per share was -$1.23.

Revenue	9.93M
Gross Profit	5.11M
Operating Income	-11.17M
Pretax Income	-11.10M
Net Income	-11.10M
EBITDA	-9.02M
EBIT	-11.08M
Loss Per Share	-$1.23

Full Income Statement

Balance Sheet

The company has $5.01 million in cash and $196,244 in debt, giving a net cash position of $4.81 million or $0.53 per share.

Cash & Cash Equivalents	5.01M
Total Debt	196,244
Net Cash	4.81M
Net Cash Per Share	$0.53
Equity / Book Value	9.74M
Book Value Per Share	1.07
Working Capital	2.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.81 million and capital expenditures -$4.74 million, giving a free cash flow of -$10.55 million.

Operating Cash Flow	-5.81M
Capital Expenditures	-4.74M
Free Cash Flow	-10.55M
FCF Per Share	-$1.17

Full Cash Flow Statement

Margins

Gross margin is 51.45%, with operating and profit margins of -112.50% and -111.80%.

Gross Margin	51.45%
Operating Margin	-112.50%
Pretax Margin	-111.80%
Profit Margin	-111.80%
EBITDA Margin	-90.83%
EBIT Margin	-111.64%
FCF Margin	-106.28%

Dividends & Yields

iSpecimen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.23%
Shareholder Yield	-2.23%
Earnings Yield	-435.90%
FCF Yield	-414.41%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

iSpecimen has an Altman Z-Score of -6.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.52
Piotroski F-Score	2